Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The latest news, stories and exciting findings from across the Oxford cancer research community

Mechanism behind repair of cancer-inducing mutations discovered

New research from Ross Chapman’s lab has discovered the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

Oxford Cancer – behind the brand

Our new brand represents how Oxford researchers are working across disciplines to translate their discoveries into better care for cancer patients. Meet the new brand and the people behind it.

AI software to help clinicians diagnose lung cancer earlier and reduce patient waiting lists

A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding.

Protein structure solution paves way for improved anti-cancer drugs

A new study from the Newstead group at the Department of Biochemistry has solved the structure of the human folate transporter, paving the way for improved anticancer drugs.

New network Oxford Cancer launches

A new pan-divisional initiative has launched at the University of Oxford. Bringing together the collective force of cancer research, outreach and care that happen across the city of Oxford.

The next step in personalised cancer medicine

Botnar Research Centre researchers have developed standalone long-read sequencing of single cells technology that could open new avenues into the causes of diseases like cancer.

Oxford Cancer welcomes Professor Stefan Constantinescu

Professor Stefan Constantinescu joins Ludwig Oxford to expand his research programme in cancer epigenetics.

Study investigating targeted drug delivery by focused ultrasound for pancreatic cancer opens

University of Oxford researchers have begun recruitment to a study looking at whether chemotherapy medication can reach pancreatic tumours more effectively if encapsulated within a heat-sensitive shell and triggered with focused ultrasound.

14 new CRUK Oxford Centre Development Fund Awardees

The awardees from the 2021 round of the CRUK Oxford Centre Development fund have been announced. Read about what research they will be undertaking.

Oxford wins government funding to evaluate prostate cancer detection system

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University.

Two clinical academic research partnerships awarded to Oxford researchers

Congratulations to Dr Karthik Ramasamy & Dr John Jacob on their CARP awards from the Medical Research Council. Find more about their work that is being funded.

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Early diagnosis of lymphoma in children and young adults in sub-Saharan Africa

A multidisciplinary team of researchers based in Oxford, Tanzania and Uganda are testing novel diagnostic tools and strengthening local capacity to improve early diagnosis of blood cancers called lymphomas, common diseases in children and young adults in sub-Saharan Africa

Reduced antibody response to COVID vaccination in myeloid blood cancers patients

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

AI endoscopy project enables 3D surface measurements of Barrett's oesophagus

Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.

Groundbreaking FOCUS4 clinical trials report their findings at ASCO

Principal Investigator Tim Maughan talks about the forward-thinking approach of the FOCUS4 cancer clinical trials and how they have helped shape the UK's fight against COVID-19

The nervous system & cancer progression

Using her new CRUK Oxford Centre Development Fund award, Dr Linna Zhou will investigate the role of the nervous system in cancer progression using engineered gastrointestinal tissues.

Eoghan Mulholland awarded colorectal cancer fellowship

As part of UK Pride month, we are spotlighting the work of cancer researcher and University LGBTQ+ Representative Dr Eoghan Mulholland

Artificial intelligence tool for streamlining pathology workflow

A multidisciplinary team in Oxford has developed an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.

Cancer immunologist Lieping Chen joins Ludwig Oxford as a Visiting Professor

Oxford is delighted to welcome this acclaimed scientist to the Ludwig Oxford community.

Load More